Clin2
NCT07372703Possibly a fitRecruiting

Safety study of VV913 capsules in healthy Chinese men

Healthy Volunteers

Treatments studied

This study tests a new capsule called VV913 in healthy male volunteers to see how safe it is and how the body processes it. It is a first-in-human trial in China to gather basic safety information.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
56 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You must be a male between 18 and 45 years old.
  • Your weight must be at least 50 kg (110 lbs) and your body mass index (weight to height ratio) must be between 19 and 26.
  • You must be generally healthy, with normal vital signs, lab tests, and no significant medical conditions.
  • You must agree to use effective birth control during the study and for 3 months after.
  • You cannot have taken any medications (prescription, over-the-counter, herbal) in the last 2 weeks.
  • You must be willing to avoid alcohol, smoking, certain foods and drinks (like grapefruit, coffee, chocolate) for 48 hours before and during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07507838Recruiting· Early Phase 1
Safety study of VV913 capsules in healthy male volunteers

This early-phase trial tests VV913 capsules in healthy men to see how safe they are and how the body processes the drug. It may help find the right dose for future studies.

Hefei, Anhui
NCT07302269Recruiting· Phase 1
Safety study of VV261 tablets in healthy Chinese volunteers

This trial tests a new tablet called VV261 in healthy volunteers to see how safe it is and how the body processes it. It is an early study to gather important information before larger trials.

Hefei, Anhui
NCT07710326Not yet recruiting· Phase 1
Safety study of VV261 tablets in healthy volunteers

This study tests a new tablet called VV261 in healthy volunteers. It looks at how the drug moves through the body and how safe it is when taken multiple times. It may help show if the drug is promising for future treatments.

Hefei, Anhui
NCT07240636Recruiting· Phase 1
How food affects a new medicine in healthy volunteers

This trial studies how food changes the way your body processes a new medicine called VV119. It helps make sure the drug works safely and effectively. Healthy adults are needed to participate.

Hefei, Anhui
NCT07565792Recruiting· Phase 1
How Food Affects a New Drug in Healthy Men

This study tests how eating food changes how your body absorbs a new experimental drug called VV913. Researchers will give you the drug with and without food to see if meals make a difference in how well it works.

Hefei, Anhui
NCT06081465Recruiting· Phase 1
Testing a new drug in healthy volunteers

This study tests a new oral medication, VG290131, in healthy volunteers to see how the body processes it and if it is safe. It is an early-phase trial that requires participants to be in good health and follow specific rules about medications and lifestyle.

Nedlands, Western Australia

Hear when a new Healthy Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.